Abstract
Recently, the burden of coronary events in patients with acute coronary syndrome (ACS) has increased with a high recurrence rate and mortality. The management of blood lipid levels in patients with ACS is challenging under the current treatment mode. Based on practice experience of domestic specialists and the reference of international clinical practice, together with the evidence of lipid lowering in patients with ACS, this expert consensus proposes suggestions targeting lipid-lowering interventions, commonly used lipid-lowering drugs, and the clinical pathway of lipid management in patients with ACS. This work aims to standardize the lipid management and reduce the recurrence risk of cardiovascular events in patients with ACS.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
